GALACTIC-1 Trial of Inhaled IPF Therapy to Stop High Dose, Restrict Low Dose

Peptide-coated Nanoparticles Limit Damage of IPF, Early Study Finds

Tiny particles, or nanoparticles, coated with a peptide called GSE4 prevented some features of idiopathic pulmonary fibrosis (IPF) and eased others in a rat model of this disease, scientists report. No harmful effects were associated with the use of these GSE4-loaded nanoparticles in the animals, the team added, suggesting they should…